Physician profile

Stephanie Lin

Vascular Surgery · Burlingame, CA

NPI 1598839052

$19,791.70

in general payments reported to CMS, 2019-2025

28 companies · $9,611 in 2025

The $9,611 reported for 2025 was more than what 90% of Vascular Surgery providers received nationally (typical 2025 total: $927).

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$5,843.75
Food and Beverage$5,016.22
Travel and Lodging$4,347.80

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $8,161.94 2019-2025 General - Therapies, Seismiq Lithotrip_pi, Eluvia
Medtronic, INC. $2,384.37 2021-2025 Valiant Captivia, Heli-Fx Endoanchor System, Endurant Iis
Penumbra, INC. $2,154.81 2024-2025 Indigo System, Penumbra System
Silk Road Medical, INC. $1,248.12 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent
Nuvasive, INC. $1,071.42 2019
Medtronic Vascular, INC. $1,055.97 2019-2020
W. L. Gore & Associates, INC. $1,027.43 2020-2025 Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Excluder Conformable Aaa Endoprosthesis With Active Control
Shockwave Medical, INC $814.99 2022-2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Endologix LLC $257.25 2022
Janssen Pharmaceuticals, INC $249.70 2022-2024 Xarelto
Inari Medical, INC. $242.86 2020-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Cook Medical LLC $201.24 2023-2024 Zenith, Zenith Alpha
Smith+Nephew, INC. $181.31 2022-2025 Grafix Pl, Collagenase Santyl
Lemaitre Vascular, INC. $100.96 2023-2025 Artegraft Vascular Graft, Restoreflow, Hydro Lemaitre Valvulotome
Abbott Laboratories $80.20 2023-2025 Starclose Se, Perclose Prostyle, Jeti All In One Non-Sterile Kit
Show all 28 companies
CompanyGeneral paymentsYearsTop products
Terumo Medical Corporation $76.63 2022-2024 Tr Band, Navicross, Glidesheath Slender
Pfizer INC. $70.54 2024-2025
Bard Peripheral Vascular, INC. $68.98 2019
Tactile Systems Technology INC $65.08 2023-2025 Flexitouch Plus, Nimbl, Entre Plus
Mimedx Group, INC. $56.95 2025
Ethicon US, LLC $48.63 2023-2025 Prolene, Vistaseal
Venclose INC. $32.61 2020
Sanara Medtech INC. $29.39 2025 Celleraterx
Angiodynamics, INC. $26.22 2021
Stryker Corporation $24.49 2025 Artix Mt
Walk Vascular, LLC $22.92 2021
Becton, Dickinson and Company $19.62 2024 Venclose Maven Catheter
Convatec INC. $17.07 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stephanie Lin

$19,791.70

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $9,611 reported for 2025 was more than what 90% of Vascular Surgery providers received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/208590/stephanie-lin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.